Shohei Nagakawa
Papers
2
Total Citations
16
H-Index
2
About
Shohei Nagakawa is a rising authority in urological oncology, with a focused expertise in predictive modeling for prostate cancer management. His research centers on the rigorous external validation of clinical nomograms—specifically for predicting lymph node involvement and extracapsular extension—to improve surgical decision-making in Japanese patient populations. Nagakawa’s major contribution lies in bridging the gap between Western-developed predictive tools and their applicability in Asian cohorts, ensuring that risk stratification models are both accurate and culturally relevant. His most-cited work (9 citations) validates models for lymph node involvement probability, while a companion study (7 citations) assesses extracapsular extension predictors, both leveraging data from patients undergoing robotic-assisted radical prostatectomy with extended lymph node dissection. By demonstrating which models retain their predictive power in a Japanese context, Nagakawa provides clinicians with evidence-based guidance for tailoring treatment—potentially sparing patients unnecessary lymphadenectomy or aiding in nerve-sparing approaches. His work underscores the critical importance of external validation in personalized oncology, marking him as a key contributor to precision prostate cancer care in Japan.
Research Focus
Key Achievements
Top Papers
- 1
- 2